Martin Joyce - Jun 10, 2025 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Martin Joyce
Stock symbol
ALDX
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 04:27 PM
Previous filing
Jun 6, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
JOYCE MARTIN JOSEPH Director C/O ALDEYRA THERAPEUTICS, INC., 131 HARTWELL AVENUE, LEXINGTON /s/ Martin Joyce 2025-06-12 0001300858

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +62.7K $0.00 62.7K Jun 10, 2025 Common Stock 62.7K $2.69 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +1.69K $0.00 1.69K Jun 10, 2025 Common Stock 1.69K $2.69 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +7.24K $0.00 7.24K Jun 10, 2025 Common Stock 7.24K $2.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.